scholarly journals The relationship between serum-free insulin-like growth factor-1 and metabolic syndrome in school adolescents of northeast China

2019 ◽  
Vol Volume 12 ◽  
pp. 305-313
Author(s):  
Shuang Xie ◽  
Ranhua Jiang ◽  
Wanfeng Xu ◽  
Yu Chen ◽  
Lei Tang ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Growth Factor ◽  
Northeast China ◽  
Insulin Like Growth Factor ◽  
Serum Free ◽  
Free Insulin ◽  
The Relationship

scholarly journals Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure

1999 ◽  
Vol 56 (6) ◽  
pp. 2076-2084 ◽  
Author(s):  
Jan Frystyk ◽  
Per Ivarsen ◽  
Christian Skjærbæk ◽  
Allan Flyvbjerg ◽  
Erling Bjerregaard Pedersen ◽  
...  
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Growth Factor ◽  
Insulin Like Growth Factor ◽  
Serum Free ◽  
Factor I ◽  
Free Insulin ◽  
Growth Factor I

The relationship between insulin-like growth factor-1 and metabolic syndrome, independent of adiponectin

2012 ◽  
Vol 413 (3-4) ◽  
pp. 506-510 ◽  
Author(s):  
Jaewon Oh ◽  
Jong-Youn Kim ◽  
Sungha Park ◽  
Jong-Chan Youn ◽  
Nak Hoon Son ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Growth Factor ◽  
Insulin Like Growth Factor ◽  
The Relationship

Serum free insulin-like growth factor-I is dose-dependently decreased by methylprednisolone and related to body weight changes in rats

1999 ◽  
Vol 9 (1) ◽  
pp. 74-80 ◽  
Author(s):  
Christian Skjærbæk ◽  
Jan Frystyk ◽  
Thorbjørn Grøfte ◽  
Allan Flyvbjerg ◽  
Moira S. Lewitt ◽  
...  
Keyword(s):  
Body Weight ◽  
Growth Factor ◽  
Insulin Like Growth Factor ◽  
Weight Changes ◽  
Body Weight Changes ◽  
Serum Free ◽  
Factor I ◽  
Free Insulin ◽  
Growth Factor I

Serum free insulin-like growth factor-I decreases during the night in healthy subjects and acromegalic patients but not in growth-hormone-deficient patients

1998 ◽  
Vol 8 (4) ◽  
pp. 337 ◽  
Author(s):  
C Skj˦rbr˦k ◽  
J Frystyk ◽  
A Kaal ◽  
T Laursen ◽  
J Møller ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Growth Factor ◽  
Healthy Subjects ◽  
Insulin Like Growth Factor ◽  
Serum Free ◽  
Factor I ◽  
Free Insulin ◽  
Growth Factor I

Lanreotide Reduces Serum Free and Total Insulin-Like Growth Factor-I After Angioplasty

Circulation ◽  
1996 ◽  
Vol 94 (10) ◽  
pp. 2465-2471 ◽  
Author(s):  
Jan Frystyk ◽  
Christian Skjærbæk ◽  
Niels Alexander ◽  
Håkan Emanuelsson ◽  
Harry Suryapranata ◽  
...  
Keyword(s):  
Growth Factor ◽  
Insulin Like Growth Factor ◽  
Serum Free ◽  
Factor I ◽  
Growth Factor I

scholarly journals Insulin-like growth factor-1 and myocardial remodeling in female patients with arterial hypertension and metabolic syndrome

2015 ◽  
Vol 11 (5) ◽  
pp. 489-495
Author(s):  
A. N. Zakirova ◽  
E. R. Fatkullina ◽  
N. E. Zakirova ◽  
L. M. Zhamalov
Keyword(s):  
Metabolic Syndrome ◽  
Growth Factor ◽  
Arterial Hypertension ◽  
Insulin Like Growth Factor ◽  
Myocardial Remodeling ◽  
Female Patients

Longitudinal bone growth in vitro: effects of insulin-like growth factor I and growth hormone

1991 ◽  
Vol 124 (5) ◽  
pp. 602-607 ◽  
Author(s):  
Ben A. A. Scheven ◽  
Nicola J. Hamilton
Keyword(s):  
Growth Hormone ◽  
Growth Factor ◽  
Bone Growth ◽  
Long Bone ◽  
Long Bones ◽  
Insulin Like Growth Factor ◽  
Serum Free ◽  
Factor I ◽  
Igf I

Abstract. Longitudinal growth was studied using an in vitro model system of intact rat long bones. Metatarsal bones from 18- and 19-day-old rat fetuses, entirely (18 days) or mainly (19 days) composed of chondrocytes, showed a steady rate of growth and radiolabelled thymidine incorporation for at least 7 days in serum-free media. Addition of recombinant human insulin-like growth factor-I to the culture media resulted in a direct stimulation of the longitudinal growth. Recombinant human growth hormone was also able to stimulate bone growth, although this was generally accomplished after a time lag of more than 2 days. A monoclonal antibody to IGF-I abolished both the IGF-I and GH-stimulated growth. However, the antibody had no effect on the growth of the bone explants in control, serum-free medium. Unlike the fetal long bones, bones from 2-day-old neonatal rats were arrested in their growth after 1-2 days in vitro. The neonatal bones responded to IGF-I and GH in a similar fashion as the fetal bones. Thus in this study in vitro evidence of a direct effect of GH on long bone growth via stimulating local production of IGF by the growth plate chondrocytes is presented. Furthermore, endogenous growth factors, others than IGFs, appear to play a crucial role in the regulation of fetal long bone growth.

Sign in / Sign up

Export Citation Format

Share Document